Home › NDC Lookup › RxCUI directory › RxCUI 1726321

2 ML irinotecan hydrochloride 20 MG/ML Injection [Camptosar] — RxCUI 1726321

Name: 2 ML irinotecan hydrochloride 20 MG/ML Injection [Camptosar] (RxCUI 1726321)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1726321 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726321

Official name2 ML irinotecan hydrochloride 20 MG/ML Injection [Camptosar]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as2 ML Camptosar 20 MG/ML Injection; Camptosar 40 MG in 2 ML Injection; Camptosar 40 MG per 2 ML Injection

FDA products mapped3

Package NDCs mapped4

Reported Medicaid activity (SDUD)508 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Irinotecan Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Irinotecan is a chemotherapy drug used for colorectal cancer — specifically cancer of the colon or rectum that has spread to other parts of the body. It can be used as part of your...
What exactly is irinotecan being used to treat?
Irinotecan is given through an IV drip — it's not a pill. Each infusion typically takes about 90 minutes and is done in a clinic or infusion center. How often you go in depends on...
How will I receive this medication, and how often will I need to go in?

📖 Read our full Irinotecan Injection guide →

🕸️ Concept Web — How 2 ML irinotecan hydrochloride 20 MG/ML Injection... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML irinotecan hydrochloride 20 MG/ML Injection [Camptosar] RxCUI 1726321 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Irinotecan 51499 IN
- Irinotecan hydrochloride 153329 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Camptosar 203652 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Irinotecan Injection 1726318 SCDF
- Irinotecan hydrochloride Injection 2647503 SCDFP
- Irinotecan Injectable Product 1161334 SCDG
- Irinotecan hydrochloride Injectable Product 2660189 SCDGP
- Irinotecan Injection [Camptosar] 1726320 SBDF
- Irinotecan hydrochloride Injection [Camptosar] 2656798 SBDFP
- Camptosar Injectable Product 1172305 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2 ML irinotecan hydrochloride 20 MG/ML Injection 1726319 SCD
- Irinotecan hydrochloride 20 MG/ML 904159 SCDC
- Irinotecan hydrochloride 20 MG/ML [Camptosar] 904161 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2 ML irinotecan hydrochloride 20 MG/ML Injection SCD · 1726319
Irinotecan hydrochloride 20 MG/ML SCDC · 904159
Irinotecan Injection SCDF · 1726318
Irinotecan hydrochloride Injection SCDFP · 2647503
Irinotecan Injectable Product SCDG · 1161334
Irinotecan hydrochloride Injectable Product SCDGP · 2660189

Brand-Name Concepts

Irinotecan hydrochloride 20 MG/ML [Camptosar] SBDC · 904161
Irinotecan Injection [Camptosar] SBDF · 1726320
Irinotecan hydrochloride Injection [Camptosar] SBDFP · 2656798
Camptosar Injectable Product SBDG · 1172305
Camptosar BN · 203652

📦 FDA Products & Package NDCs

3 products · 4 package NDCs

4 package NDCs map to RxCUI 1726321 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00009-0082-02	1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0082-02) / 15 mL in 1...	Camptosar	Pharmacia & Upjohn Company LLC	2024-06-24
00009-0112-05	1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0112-05) / 5 mL in 1...	Camptosar	Pharmacia & Upjohn Company LLC	2024-12-30
00009-7529-05	1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05) / 15 mL in 1...	Camptosar	Pharmacia & Upjohn Company LLC	1996-06-14
00009-7529-10	1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-10) / 2 mL in 1...	Camptosar	Pharmacia & Upjohn Company LLC	2024-12-30

Observed labelers: Pharmacia & Upjohn Company LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9206	Irinotecan injection	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.